Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo.
Kozielski KL, Ruiz-Valls A, Tzeng SY, Guerrero-Cázares H, Rui Y, Li Y, Vaughan HJ, Gionet-Gonzales M, Vantucci C, Kim J, Schiapparelli P, Al-Kharboosh R, Quiñones-Hinojosa A, Green JJ.
Kozielski KL, et al. Among authors: kim j.
Biomaterials. 2019 Jul;209:79-87. doi: 10.1016/j.biomaterials.2019.04.020. Epub 2019 Apr 12.
Biomaterials. 2019.
PMID: 31026613
Free PMC article.